Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

therapy-related acute myeloid leukemia

(THAYR-uh-pee-ree-LAY-ted uh-KYOOT MY-eh-loyd loo-KEE-mee-uh)
A type of acute myeloid leukemia (AML) that is caused by previous treatment with chemotherapy or radiation therapy. Therapy-related acute myeloid leukemia is an aggressive (fast-growing) cancer in which there are too many myeloblasts (immature white blood cells) in the blood or bone marrow. Therapy-related acute myeloid leukemia usually occurs within 7 years after treatment. It is more common in adults. Also called t-AML.
Search NCI's Dictionary of Cancer Terms